Anaam Mohammed Saif, AlShibl Dalia A, Alfadly Saeed, Aloyuni Munirah Yousef, Al Harbi Fawaz Hamdan, Alhmoud Hussam, Alhomoud Ibrahim S, Altowayan Waleed Mohammad
Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Pharmacy Department, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia.
Healthcare (Basel). 2025 Jul 7;13(13):1617. doi: 10.3390/healthcare13131617.
Oral isotretinoin is an effective treatment for refractory and moderate acne unresponsive to conventional therapies, considered the most effective option for such cases.
This study aimed to evaluate the knowledge, concerns, and experiences of acne patients undergoing isotretinoin treatment in Qassim, Saudi Arabia, with a focus on commonly reported adverse effects.
A cross-sectional study was conducted from December 2023 to February 2024 using a self-administered questionnaire. This study targeted male and female acne vulgaris patients from the Qassim region attending the outpatient dermatology clinic at King Saud Hospital (KSH).
A total of 131 acne patients participated. Of these, 97.7% had heard of isotretinoin, and 92.4% were aware of its side effects. The most common sources of information were colleagues, friends, or family (37.4%), followed by previous use (26%) and healthcare professionals (24%). The most frequently reported side effect was dryness (51.9%), followed by liver function changes (24.4%) and fetal abnormalities (13%). There was a significant association between educational level and knowledge of isotretinoin's side effects ( = 0.003) and awareness of specific side effects ( < 0.001).
Most acne patients had sufficient knowledge of isotretinoin and its adverse effects, with dryness being the most commonly reported side effect. The primary sources of information were non-medical, highlighting the need for health education to ensure informed and safe isotretinoin use.
口服异维A酸是治疗对传统疗法无反应的难治性中度痤疮的有效方法,被认为是此类病例的最有效选择。
本研究旨在评估沙特阿拉伯卡西姆地区接受异维A酸治疗的痤疮患者的知识、担忧和经历,重点关注常见的不良反应。
2023年12月至2024年2月进行了一项横断面研究,使用自填式问卷。本研究针对卡西姆地区在沙特国王医院(KSH)门诊皮肤科就诊的寻常痤疮男女患者。
共有131名痤疮患者参与。其中,97.7%听说过异维A酸,92.4%知晓其副作用。最常见的信息来源是同事、朋友或家人(37.4%),其次是既往使用经历(26%)和医疗保健专业人员(24%)。最常报告的副作用是皮肤干燥(51.9%),其次是肝功能变化(24.4%)和胎儿异常(13%)。教育水平与异维A酸副作用知识( = 0.003)和特定副作用知晓率( < 0.001)之间存在显著关联。
大多数痤疮患者对异维A酸及其不良反应有足够的了解,皮肤干燥是最常报告的副作用。信息的主要来源是非医疗方面的,这凸显了健康教育对于确保安全、明智地使用异维A酸的必要性。